Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Composite Resins Reconditioned, Behavior and Survival: Clinical Follow-up 10 Years (reacondcomp)

20. august 2014 opdateret af: Eduardo Fernandez, University of Chile
The purpose of this study is to evaluate the clinical performance of resin composite restorations refurbished and compare with 2 groups of resins, 1 without treatment and another replaced resins acted as controls. The null hypothesis of this study is that the group of refurbished resins have a similar behavior to the control groups.

Studieoversigt

Status

Afsluttet

Detaljeret beskrivelse

A cohort of 26 patients aged 18-80 years old (mean: 28.35 years; 42% men, 58% women) with 78 composite restorations (Class I: 39; Class II: 39) were recruited at the Operative Dentistry Clinic at the Dental School of the University of Chile. All participants in the refurbishing groups showed clinical features for the anantomy, roughness and/or luster that deviated from the ideal and were rated Bravo according to the modified United States Public Health Service (USPHS) criteria. New Composites with Alpha values (Replacement group) and acceptable composites (No treatment group) were used as controls. The protocol was approved by the Institutional Research Ethics Committee of the Dental School at the University of Chile (Project PRI-ODO-0207). All patients signed informed-consent forms and completed registration forms

General Inclusion Criteria:

  • Patients with more than 20 teeth.
  • Restorations in functional occlusion, with an opposing natural tooth.
  • Asymptomatic restored tooth.
  • At least one proximal contact area with a neighboring tooth.
  • Patients older than 18 years.
  • Patients who agreed and signed a consent form for participating in the study.
  • Area outside of the restoration failure is in good condition.

General Exclusion Criteria:

  • Patients with contra-indications for regular dental treatment based on their medical history.
  • Patients with xerostomia or individuals taking medication that significantly decreased salivary flow.
  • Patients with a high risk of caries.
  • Patients with psychiatric or physical diseases, which interfered with oral hygiene.

Treatment Group Criteria Two hundred four patients were initially evaluated and assigned in accordance with the modified USPHS criteria,26 patients were selected based on the inclusion criteria with at least 1 Composite restoration with anatomy, roughness and/or luster (Bravo) suitable for reburbishing, with another composite restorations that had excellent values (Alpha) and was made at this time (Replacement group).And finally another composite pre-existing with acceptable condition (Alpha or Bravo values) acted as control. The patient was considered the statistical unit in this study (n=20).

Restoration Assessment The quality of the restorations was scored in accordance with the modified USPHS criteria. The Cohen Kappa inter-examiner coefficient was 0.74 in the first year and 0.87 after 10 years for two examiners (JM and EF) who underwent calibration training exercises each year. In the first, second, third, fourth, fifth, and tenth years, the examiners independently assessed the restorations for anatomic form, roughness, color, marginal staining,luster, secondary caries, marginal and marginal adaptation, both directly via tactile and visual examinations with mouth mirror number five and explorer number 23 (Hu Friedy Mfg. Co. Inc.) and indirectly by radiographic examination (bite wing). A third clinician (GM), who also underwent the calibration training exercises, made the final decision if a difference was recorded between the two examiners and they could not reach an agreement.

Treatment Groups Refurbishing For this group, The dentists finished the occlusal, lingual or facial surfaces of defective RBC restorations with the medium series of aluminum oxide disks (Sof-Lex,3M ESPE) or carbide burs (12 and 30 blades,Brasseler USA, Dental Instrumentation,Savannah, Ga.) and then polished them with afine series of aluminum oxide disks (Sof-Lex, 3M ESPE) and diamond-impregnated composite polisher (ComposiPro Diacomp, Brasseler). For restorations in which proximal surface areas were affected, the clinicians smoothed them with interproximal aluminum oxide finishing strips (Sof-Lex Finishing Strips, 3M ESPE).

Replacement group Composite resins with Alpha values for the marginal adaptation criteria were used as the positive control and were made with resin composite (Filtek Supreme, 3M ESPE), eith rubber dam isolation and the adhesive system L-Pop Prompt (3M-ESPE) No treatment Composite resin restorations (Z100, 3M ESPE) in general clinically acceptable, did not receive treatment.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

25

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Santiago, Chile, 7500505
        • Eduardo Fernandez Godoy

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Any person with composite restorations

Beskrivelse

Inclusion Criteria:

  • Patients with more than 20 teeth.
  • Restorations in functional occlusion, with an opposing natural tooth.
  • Asymptomatic restored tooth.
  • At least one proximal contact area with a neighboring tooth.
  • Patients older than 18 years.
  • Patients who agreed and signed a consent form for participating in the study.
  • Area outside of the restoration failure is in good condition.

Exclusion Criteria:

  • Patients with contra-indications for regular dental treatment based on their medical history.
  • Patients with xerostomia or individuals taking medication that significantly decreased salivary flow.
  • Patients with a high risk of caries.
  • Patients with psychiatric or physical diseases, which interfered with oral hygiene.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Replacement
Composite resins with Alpha values for the marginal adaptation criteria were used as the positive control and were made with resin composite (Filtek Supreme, 3M ESPE), eith rubber dam isolation and the adhesive system L-Pop Prompt (3M-ESPE)
No treatment
Composite resin restorations (Z100, 3M ESPE) in general clinically acceptable, did not receive treatment.
Refurbishing
For this group, The dentists finished the occlusal, lingual or facial surfaces of defective RBC restorations with the medium series of aluminum oxide disks (Sof-Lex,3M ESPE) or carbide burs (12 and 30 blades,Brasseler USA, Dental Instrumentation,Savannah, Ga.) and then polished them with afine series of aluminum oxide disks (Sof-Lex, 3M ESPE) and diamond-impregnated composite polisher (ComposiPro Diacomp, Brasseler). For restorations in which proximal surface areas were affected, the clinicians smoothed them with interproximal aluminum oxide finishing strips (Sof-Lex Finishing Strips, 3M ESPE).

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Ændringer i kvaliteten af ​​restaureringer
Tidsramme: 1 år
Kvaliteten af ​​restaureringerne blev bedømt i henhold til de modificerede USPHS-kriterier. To eksaminatorer gennemgik kalibreringsøvelser hvert år (JM og EF). Umiddelbart efter behandlingen (baseline) og 10 år senere vurderede eksaminatorerne restaureringerne uafhængigt ved direkte visuel og taktil undersøgelse med mundspejl nummer 5 og explorer nummer 23 (Hu Friedy Mfg. Co. Inc., Chicago, IL, USA) og indirekte ved røntgenundersøgelse (bidvinge). De fire undersøgte parametre var anatomisk form, sekundær caries, marginal farvning og marginal tilpasning. Hvis forskellen blev registreret mellem de to eksaminatorer, og hvis de ikke kunne nå til enighed, tog en tredje kliniker, som også gennemgik kalibreringsøvelserne (GM), den endelige beslutning.
1 år

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: eduardo fernandez, University of Chile

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. maj 2003

Primær færdiggørelse (Faktiske)

1. december 2013

Studieafslutning (Faktiske)

1. december 2013

Datoer for studieregistrering

Først indsendt

19. august 2014

Først indsendt, der opfyldte QC-kriterier

20. august 2014

Først opslået (Skøn)

21. august 2014

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

21. august 2014

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. august 2014

Sidst verificeret

1. august 2014

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • FOUCH2012/10-4

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner